EPAC expression and function in cardiac fibroblasts and myofibroblasts

Toxicology and Applied Pharmacology

Volumn 272, Issue 2, 2013, Pages 414-422

  Olmedo, Ivonne ^a   Muñoz, Claudia ^a   Guzmán, Nancy ^a   Catalán, Mabel ^a   Vivar, Raúl ^a   Ayala, Pedro ^a   Humeres, Claudio ^a   Aránguiz, Pablo ^a   García, Lorena ^a   Velarde, Victoria ^b   Díaz Araya, Guillermo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adhesion; Cardiac fibroblast and myofibroblast; Collagen; EPAC 1; Migration; TGF beta1

Indexed keywords

ANTIPORTER; COLLAGEN GEL; EPAC 1 PROTEIN; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMAD PROTEIN; SMAD3 PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROBLAST; HEART; MYOFIBROBLAST; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

ADHESION; CARDIAC FIBROBLAST AND MYOFIBROBLAST; COLLAGEN; EPAC-1; MIGRATION; TGF-BETA1;

ANIMALS; ANIMALS, NEWBORN; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEART VENTRICLES; MYOFIBROBLASTS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 84884136392     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.06.022     Document Type: Article

References (35)

1. Aránguiz-Urroz P., Canales J., Copaja M., Troncoso R., Vicencio J., Carrillo C., Lara H., Lavandero S., Díaz Araya G. β2-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochim. Biophys. Acta 2011, 1812:23-31.
2. Bos J. EPAC proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 2006, 31:680-686.
3. Catalán M., Smolic C., Contreras A., Ayala P., Olmedo I., Copaja M., Boza P., Vivar R., Avalos Y., Lavandero S., Velarde V., Díaz Araya G. Differential regulation of collagen secretion by kinin receptors in cardiac fibroblasts and myofibroblasts. Toxicol. Appl. Pharmacol. 2012, 261:300-308.
4. Copaja M., Valenzuela R., Saldaña A., Ocaranza M., Jalil J., Vio C., Lijnen P., Ordenes G., Vivar R., Lavandero S., Díaz Araya G. Early expression of monocyte chemoattractant protein-1 correlates with the onset of isoproterenol-induced cardiac fibrosis in rats with distinct angiotensin-converting enzyme polymorphism. J. Renin Angiotensin Aldosterone Syst. 2008, 9:154-162.
5. Copaja M., Venegas D., Aránguiz P., Canales J., Vivar R., Catalán M., Olmedo I., Rodríguez A., Chiong M., Leyton L., Lavandero S., Díaz Araya G. Simvastatin induces apoptosis by a Rho-dependent mechanism in cultured cardiac fibroblasts and myofibroblasts. Toxicol. Appl. Pharmacol. 2011, 255:57-64.
6. Derynck R., Zhang Y. Smad dependent and Smad independent pathways in transforming growth factor family signal. Nature 2003, 425:577-584.
7. Diaz-Araya G., Borg T., Lavandero S., Loftis M., Carver W. IGF-1 modulation of rat cardiac fibroblast behavior and gene expression is age-dependent. Cell Commun. Adhes. 2003, 10:155-165.
8. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003, 200:500-503.
9. Gloerich M., Bos J. EPAC: defining a new mechanism for cAMP action. Annu. Rev. Pharmacol. Toxicol. 2010, 50:355-375.
10. Hinz B. Master and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur. J. Cell Biol. 2006, 85:175-181.
11. Huang S., Wettlaufer S., Chung J., Peters-Golden M. Prostaglandin E2 inhibits specific lung fibroblast function via selective actions of PKA and EPAC-1. Am. J. Respir. Cell Mol. Biol. 2008, 39(4):482-489.
12. Javelaud D., Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene 2005, 24:5742-5750.
13. Leask A. TGF-β cardiac fibroblasts and their fibrotic response. Cardiovasc. Res. 2007, 74:207-212.
14. Li P., Wang D., Lucas J., Oparil S., Xing D., Cao X., Novak L., Renfrow M., Chen Y. Atrial natriuretic peptide inhibits transforming growth factor β induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ. Res. 2008, 102:185-192.
15. Li H., Yuan X., Tang J., Zhang Y. LPS disrupts the directional persistence of alveolar myofibroblast migration through EGF receptor. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 302:569-570.
16. Lijnen P., Petrov V., Fagard R. Transforming growth factor β1 mediated gel contraction by cardiac fibroblasts. J. Renin Angiotensin Aldosterone Syst. 2003, 4:113-117.
17. Liu X., Sun Q., Hassid A., Ostrom R. cAMP inhibits transforming growth factor-β-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts. Mol. Pharmacol. 2006, 70:1992-2003.
18. Liu S., Shi-Wen X., Kennedy L., Pala D., Chen Y., Eastwood M., Carter D., Black C., Abraham D., Leask A. FAK is required for TGF-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype. Mol. Biol. Cell 2007, 18:2169-2178.
19. Liu Y., Ye W., Zeng X., Ren W., Zhang Y. Kr channels and cAMP-PKA pathway modulate TGF-β 1 induced migration of rat vascular myofibroblasts. J. Cell. Physiol. 2008, 216:835-843.
20. Lyle K., Raaijmakers J., Bruinsma W., Bos J., Rooij J. cAMP-induced EPAC-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics. Cell. Signal. 2008, 20:1104-1116.
21. Massagué J. How cells read TGF-β signals. Nat. Rev. Mol. Cell Biol. 2009, 1:169-178.
22. Mc Anulty R. Fibroblasts and myofibroblasts: their source, function and role in disease. Int. J. Biochem. Cell Biol. 2006, 39:666-667.
23. Ocaranza M., Díaz Araya G., Chiong M., Muñoz D., Riveros J., Ebensperger R., Sabat S., Irarrázabal P., Jalil J., Lavandero S. Influence of isoproterenol on the expression of angiotensin I-converting enzyme in lung, left ventricle and plasma during the development and regression of myocardial hypertrophy and fibrosis. J. Cardiovasc. Pharmacol. 2002, 40:246-254.
24. Porter K., Turner N. Cardiac fibroblasts: at the heart of myocardial remodelling. Pharmacol. Ther. 2009, 123:255-278.
25. Pullar C., Isserof F. β2-adrenergic receptor activation delays dermal fibroblast-mediated contraction of collagen gels via a cAMP-dependent mechanism. Wound Repair Regen. 2005, 13:405-411.
26. Rangarajan S., Enserink J., Kuiperij H., Rooij J., Price L., Schwede F., Bos J. cAMP induces integrin-mediated cell adhesion through EPAC and Rap 1 upon stimulation of the β2 adrenergic receptor. J. Cell Biol. 2003, 160:487-493.
27. Sun Y., Weber K. Animal models of cardiac fibrosis. Methods Mol. Med. 2005, 117:273-290.
28. Tomasek J., Gabbiani G., Hinz C., Chaponnier R. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat. Rev. Mol. 2002, 3:349-363.
29. Ulucan C., Wang X., Baljinnyam E., Bai Y., Okumura S., Sato M., Minamisawa S., Hirotani Y., Ishikawa Y. Developmental changes in gene expression of EPAC and its upregulation in myocardial hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:1662-1672.
30. Van den Borne S., Diez J., Blankesteijn W., Verjans J., Hosfstra L., Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 2009, 1:1-8.
31. Villarreal F., Epperson S., Ramírez I., Yamazaki K., Brunton L. Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for EPAC and PI3K. Am. J. Physiol. Cell Physiol. 2009, 296:1178-1184.
32. Voloshenyuk T., Landesman E., Khoutorova E., Hart A., Gardner J. Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. Cytokine 2011, 55:90-97.
33. Weber K., Sun Y. Recruitable ACE and tissue repair in the infarcted heart. J. Renin Angiotensin Aldosterone Syst. 2000, 14:295-303.
34. Yokoyama U., Patel H., Lai N., Aroonsakool N., Roth D., Insel P. The cyclic AMP effector EPAC integrates pro- and anti-fibrotic signals. PNAS 2008, 105:6386-6391.
35. Zhang Y. Non Smad pathways in TGF-β signaling. Cell Res. 2009, 19:128-139.